The effect of clodronate on the integrity and viability of rat small intestine in vitro - A comparison with EDTA

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 7, 2005, Pages 1249-1253

  Žakelj, Simon ^a   Vadnjal, Lea ^a   Kristl, Albin ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Calcium depletion; Clodronate; EDTA; Paracellular permeability enhancer; Rat jejunum; Side by side diffusion chamber

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHELATING AGENT; CALCIUM ION; CLODRONIC ACID; EDETIC ACID;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE POTENTIAL; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSION; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; GASTROINTESTINAL SYMPTOM; IN VITRO STUDY; JEJUNUM; MALE; NONHUMAN; RAT; SMALL INTESTINE;

ANIMALS; CLODRONIC ACID; EDETIC ACID; JEJUNUM; MALE; RATS; RATS, WISTAR;

EID: 24944570545     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1249     Document Type: Article

References (17)

1. Ward P. D., Tippin T. K., Thakker D. R., Pharm. Sci. Technol. Today, 3, 346-358 (2000).
2. Green J. R., Clay V., Richardson J., Hassan I. F., Int. J. Pharm., 153, 59-66 (1997).
3. Watts N. B., Rheum. Dis. Clin. North Am., 20, 717-734 (1994).
4. Rogers M. J., Curr. Pharm. Des., 9, 2643-2658 (2003).
5. Boulenc X., Roques C., Joyeux H., Berger Y., Fabre G., Int. J. Pharm., 123, 13-24 (1995).
6. Twiss I. M., Burggraaf J., Schoemaker R. C., van Elburg R. M., den Hartigh J., Cohen A. F., Vermeij P., Clin. Pharmacol. Ther., 69, 431-437 (2001).
7. Yakatan G. J., Poynor W. J., Talbert R. L., Floyd B. F., Slough C. L., Ampulski R. S., Benedict J. J., Clin. Pharmacol. Ther., 31, 402-410 (1982).
8. Pentikäinen P. J., Elomaa I., Nurmi A. K., Kärkkäinen S., Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 222-228 (1989).
9. 〈http://www.drugs.com/MMX/Clodronate_Disodium.html〉 accsessed 7. Dec. (2004).
10. Villikka K., Perttunen K., Rosnell J., Ikvalko H., Vaho H., Pylkknen L., Bone, 31, 418-421 (2002).
11. Agency for drugs of Republic of Slovenia, Bonefos 800 mg film coated tablets, Summary of product characteristics, last revised 11. Oct. 2002.
12. Amidon G. L., Lennernas H., Shah V. P., Crison J. R., Pharm. Res., 12, 413-420 (1995).
13. Rinaki E., Valsami G., Macheras P., Pharm. Res., 20, 1917-1925 (2003).
14. Tomita M., Hayashi M., Awazu S., J. Pharm. Sci., 85, 608-611 (1996).
15. Zakelj S., Legen I., Veber M., Kristl A., Int. J. Pharm., 272, 173-180 (2004).
16. Söderholm J. D., Hedman L., Artursson P., Franzén L., Larsson J., Pantzar N., Permert J., Olaison G., Acta Physiol. Scand., 162, 47-56 (1998).
17. Raiman J., Törmalehto S., Yritys K., Junginger H. E., Mönkkönen J., Int. J. Pharm., 261, 129-136 (2003).